- Home
- ARQT vs ARLO Comparison
ARQT vs ARLO Comparison
Compare ARQT & ARLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- ARLO
- Stock Information
- Founded
- ARQT 2016
- ARLO 2018
- Country
- ARQT United States
- ARLO United States
- Employees
- ARQT N/A
- ARLO N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- ARLO Consumer Electronics/Appliances
- Sector
- ARQT Health Care
- ARLO Consumer Staples
- Exchange
- ARQT Nasdaq
- ARLO Nasdaq
- Market Cap
- ARQT 1.1B
- ARLO 1.3B
- IPO Year
- ARQT 2020
- ARLO 2018
- Fundamental
- Price
- ARQT $13.08
- ARLO $12.19
- Analyst Decision
- ARQT Strong Buy
- ARLO Strong Buy
- Analyst Count
- ARQT 5
- ARLO 3
- Target Price
- ARQT $17.00
- ARLO $19.67
- AVG Volume (30 Days)
- ARQT 2.0M
- ARLO 733.7K
- Earning Date
- ARQT 02-25-2025
- ARLO 02-27-2025
- Dividend Yield
- ARQT N/A
- ARLO N/A
- EPS Growth
- ARQT N/A
- ARLO N/A
- EPS
- ARQT N/A
- ARLO N/A
- Revenue
- ARQT $138,708,000.00
- ARLO $524,407,000.00
- Revenue This Year
- ARQT $209.03
- ARLO $6.05
- Revenue Next Year
- ARQT $49.00
- ARLO $1.59
- P/E Ratio
- ARQT N/A
- ARLO N/A
- Revenue Growth
- ARQT 182.84
- ARLO 10.49
- 52 Week Low
- ARQT $3.59
- ARLO $8.38
- 52 Week High
- ARQT $16.20
- ARLO $17.64
- Technical
- Relative Strength Index (RSI)
- ARQT 46.24
- ARLO 57.11
- Support Level
- ARQT $12.61
- ARLO $10.87
- Resistance Level
- ARQT $14.36
- ARLO $11.94
- Average True Range (ATR)
- ARQT 0.98
- ARLO 0.48
- MACD
- ARQT -0.32
- ARLO 0.09
- Stochastic Oscillator
- ARQT 13.09
- ARLO 90.00
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About ARLO Arlo Technologies Inc.
Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It provides different products and services such as, subscription based services like Arlo Secure, Arlo Total Security, Arlo Safe, and security devices, like smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras and home security systems. Geographically, the company generates majority of its revenue from the United States and rest from Spain, Ireland and other regions.